DONATE NOWDual-Action Laser Treatment for Glaucoma
Micropulse laser treatment for glaucoma, also called Micropulse Transscleral Cyclophotocoagulation (MP-TSCPC), is a procedure used to help lower intraocular pressure (IOP). The treatment uses laser energy on the ciliary body to reduce aqueous humor production, and there is also evidence that it may increase aqueous outflow to help lower eye pressure.
Cyclophotocoagulation (MP-TSCPC)
Who May Benefit From Micropulse Laser Treatment for Glaucoma?
Doctors recommend micropulse transscleral cyclophotocoagulation for patients with many types of glaucoma. They use this laser for patients who do not want incisional surgery or are poor candidates for it. Doctors also use it as an additional treatment for patients with high IOP after previous incisional surgery. Micropulse transscleral cyclophotocoagulation works for patients with mild, moderate, or severe glaucoma.
MP-TSCPC is an outpatient procedure. The patient receives a peribulbar block (anesthesia around the eye) prior to the laser. The laser, performed by your ophthalmic surgeon, takes approximately 10-15 minutes and will require the use of postoperative drops to decrease inflammation in the eye. Most patients have minimal postoperative pain. Doctors may combine the procedure with an injection of the painkiller Chlorpromazine behind the eyeball.
Because doctors make no incisions in the eyeball, patients usually have no postoperative restrictions after the procedure. You will have a patch on the eye for the first 24 hours after the procedure and your doctor will want to see you the day following the procedure in the office to check your eye pressure.
Doctors may repeat MP-TSCPC if it does not achieve the desired eye pressure.
For more information, visit Micropulse Transscleral Cyclophotocoagulation.